# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Wells Fargo analyst Stephen Baxter maintains Oscar Health (NYSE:OSCR) with a Overweight and raises the price target from $20...
Goldman Sachs analyst Nathan Rich maintains Oscar Health (NYSE:OSCR) with a Neutral and raises the price target from $16 to ...
Raymond James analyst John Ransom initiates coverage on Oscar Health (NYSE:OSCR) with a Outperform rating and announces Pric...
Goldman Sachs analyst Nathan Rich maintains Oscar Health (NYSE:OSCR) with a Neutral and raises the price target from $8 to $16.
Shares of Compass Minerals International, Inc. (NYSE: CMP) fell sharply during Thursday’s session following downbeat results.